Marker Therapeutics EPS Basic from Extraordinaries (Quarterly) Analysis

Marker Therapeutics, Inc. (MRKR)

1.50 0.00 (0.00%) USD | NASDAQ | Feb 19, 16:00

1.51 +0.01 (+0.67%) After-Hours: 20:00

View EPS Basic from Extraordinaries (Quarterly) for MRKR.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Basic from Extraordinaries (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Basic from Extraordinaries (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Basic from Extraordinaries (Quarterly) Benchmarks

Start Trial

ADMA Biologics, Inc.	--
Viridian Therapeutics, Inc.	--
ACADIA Pharmaceuticals, Inc.	--
Kiniksa Pharmaceuticals International Plc	--
Neurocrine Biosciences, Inc.	--